GINA DRAGONE: Open Payments
NPI 1609352095 · BUFFALO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$860 in 34 payments from 10 companies in 2025. Trend: 2023 $822 · 2024 $1,347 · 2025 $860
Food & beverage: $860
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 7 | $287 |
| Lilly USA, LLC | 7 | $156 |
| Otsuka America Pharmaceutical, Inc. | 8 | $143 |
| ABBVIE INC. | 3 | $73 |
| Pharmacosmos Therapeutics Inc. | 2 | $64 |
| Neurocrine BioSciences, Inc. | 2 | $44 |
| Lundbeck LLC | 2 | $42 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Life Molecular Imaging Ltd | 1 | $18 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
Products named: Leqembi, REXULTI, KISUNLA, MONOFERRIC, INGREZZA, QULIPTA, BOTOX, UBRELVY.
Industry payments across NY — which companies pay providers there.
